Gert van der Hoek
In Memoriam - Editor, Senior Moderator
In response to the Yi-Yun Liu and colleagues' finding of a mobile genetic element responsible for colistin resistance, mcr-1,1 and the accompanying Comment asking “is plasmid-mediated colistin resistance a purely Chinese phenomenon?”2, we, and others,3, 4 can now reply no. As part of routine surveillance, we screened 8684 salmonella isolates collected during 2012–13 from the French agricultural food sector for colistin resistance using disk diffusion.5 Between October and December, 2013, 27 isolates that showed a reduced susceptibility to colistin (ie, zone of inhibition <15 mm) were further assessed using a colistin concentration gradient assay. Five isolates (0?06%) had a distinctly different minimum inhibitory concentration (≥4 mg/mL) and were defined as colistin-resistant. In 2014, whole-genome sequencing of the five isolates was done and resultant sequences were assembled and interrogated for mutations and genetic elements associated with colistin resistance.
We identified mcr-1 in four of five phenotypically colistin-resistant isolates.
We identified mcr-1 in four of five phenotypically colistin-resistant isolates.
Our findings, and those of others,1 reinforce the need to reconsider the use of in-feed colistin in veterinary medicine at a worldwide level. Stewardship efforts are needed to preserve the efficacy of antimicrobial drugs for society—both now and into the future. Effective strategies that limit selection and further dissemination of plasmid-associated mcr-1 are clearly needed.
Last edited: